PSMA-1007

• UNSPSC Description:

  PSMA-1007 is a prostate-specific membrane antigen (PSMA) ligand. 18F-labeled PSMA-1007 can be used as a PET tracer for prostate cancer imaging[1].

• Target Antigen:

  PSMA; Radionuclide-Drug Conjugates (RDCs)

• Type:

  Peptides

• Related Pathways:

  Antibody-drug Conjugate/ADC Related;Immunology/Inflammation

• Applications:

  COVID-19-immunoregulation

• Field of Research:

  Others

• Assay Protocol:

  https://www.medchemexpress.com/psma-1007.html

• Solubility:

  DMSO : 125 mg/mL (ultrasonic)

• Smiles:

  OC(CC[C@H](NC([C@@H](NC(C1=CC=C([N+](C)(C)C)N=C1)=O)CCC(O)=O)=O)C(NCC2=CC=C(C(N[C@@H](CC3=CC=C(C=CC=C4)C4=C3)C(NCCCC[C@@H](C(O)=O)NC(N[C@H](C(O)=O)CCC(O)=O)=O)=O)=O)C=C2)=O)=O.[O-]C(C(F)(F)F)=O

• Molecular Weight:

  1184.13

• References & Citations:

  [1]Mamlins E, et al. PSMA-1007 Uptake in Ganglia of the Sympathetic Trunk and Its Intra-individual Reproducibility. Mol Imaging Biol. 2023 Jun;25(3):554-559.

• Shipping Conditions:

  Blue Ice

• Clinical Information:

  Phase 3

• CAS Number:

  2226894-58-0